Relevant bibliographies by topics / Bakers asthma; allergic diseases

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Bakers asthma; allergic diseases'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bakers asthma; allergic diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Bakers asthma; allergic diseases"

1

de los Reyes Jiménez, Marta, Antonie Lechner, Francesca Alessandrini, Sina Bohnacker, Sonja Schindela, Aurélien Trompette, Pascal Haimerl, et al. "An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products." Science Translational Medicine 12, no. 540 (April 22, 2020): eaay0605. http://dx.doi.org/10.1126/scitranslmed.aay0605.

Full text
Abstract:
Eicosanoids are key mediators of type-2 inflammation, e.g., in allergy and asthma. Helminth products have been suggested as remedies against inflammatory diseases, but their effects on eicosanoids are unknown. Here, we show that larval products of the helminth Heligmosomoides polygyrus bakeri (HpbE), known to modulate type-2 responses, trigger a broad anti-inflammatory eicosanoid shift by suppressing the 5-lipoxygenase pathway, but inducing the cyclooxygenase (COX) pathway. In human macrophages and granulocytes, the HpbE-driven induction of the COX pathway resulted in the production of anti-inflammatory mediators [e.g., prostaglandin E2 (PGE2) and IL-10] and suppressed chemotaxis. HpbE also abrogated the chemotaxis of granulocytes from patients suffering from aspirin-exacerbated respiratory disease (AERD), a severe type-2 inflammatory condition. Intranasal treatment with HpbE extract attenuated allergic airway inflammation in mice, and intranasal transfer of HpbE-conditioned macrophages led to reduced airway eosinophilia in a COX/PGE2-dependent fashion. The induction of regulatory mediators in macrophages depended on p38 mitogen-activated protein kinase (MAPK), hypoxia-inducible factor-1α (HIF-1α), and Hpb glutamate dehydrogenase (GDH), which we identify as a major immunoregulatory protein in HpbE. Hpb GDH activity was required for anti-inflammatory effects of HpbE in macrophages, and local administration of recombinant Hpb GDH to the airways abrogated allergic airway inflammation in mice. Thus, a metabolic enzyme present in helminth larvae can suppress type-2 inflammation by inducing an anti-inflammatory eicosanoid switch, which has important implications for the therapy of allergy and asthma.
APA, Harvard, Vancouver, ISO, and other styles
2

Ade, Serge, Mênonli Adjobimey, Gildas Agodokpessi, Marie Sylvie Kouassi, Fabien A. Gounongbe, Ibrahim Cisse, and Spero H. R. Hounkpatin. "Asthma Symptoms in Bakeries at Parakou, Benin." Pulmonary Medicine 2020 (January 30, 2020): 1–6. http://dx.doi.org/10.1155/2020/3767382.

Full text
Abstract:
Background and Objectives. There is a dearth of information on asthma among bakers in low-income settings. The objectives of this study were to determine (i) the prevalence of asthma symptoms, (ii) factors associated with probable occupational asthma (OA), and (iii) work habits that might lead to a dusty workplace environment, Parakou, Benin. Materials and Methods. This was a mixed methods (cross-sectional quantitative and qualitative) study carried out between March and September 2018. Results. Of 210 employees/apprentices in 26 bakeries, 190 (91.48%) were included in the study: median age was 25.50 (IQR=22−32) years, 157 (82.63%) were aged <40 years, and the male-to-female ratio was 26.14. Of these, 111 (58.42%) worked in a salted bread and 79 (41.58%) in a sweet bread bakery. An asthma history was reported by 3.68%. Symptoms consistent with asthma, work-related asthma, OA, and work-aggravated asthma were found in 13.68%, 12.63%, 10%, and 2.63%, respectively. Asthma confirmation was obtained in 15.79% of bakers with probable OA and in 23.08% of all bakers with suspected asthma. A history of allergic rhinoconjunctivitis was associated with probable OA (aOR=106; 95%CI=17.79−2093; p<0.001). Of the 24 bakers with probable work-related asthma, 3 (12.50%) were prescribed a short-acting beta2-agonist and 2 (8.33%) an inhaled corticosteroid. No worker had had a systematically planned annual medical visit; some habits at work were identified as leading to flour and dust suspension at the workplace. Conclusion. Clinical manifestations of OA were common among bakers in Parakou and were associated with allergic rhinoconjunctivitis. There is a need to improve technical preventive measures and treatment, as well as to institute systematic medical visits for these workers.
APA, Harvard, Vancouver, ISO, and other styles
3

Pawankar, Ruby, Giorgio W. Canonica, Stephen T. Holgate, and Richard F. Lockey. "Allergic diseases and asthma." Current Opinion in Allergy and Clinical Immunology 12, no. 1 (February 2012): 39–41. http://dx.doi.org/10.1097/aci.0b013e32834ec13b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

FRANKEN, J., and W. KONIG. "251 Analysis of allergic rye and wheat flour components in bakers' asthma disease." Journal of Allergy and Clinical Immunology 87, no. 1 (January 1991): 201. http://dx.doi.org/10.1016/0091-6749(91)91534-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gnaiger, Jutta. "Allergic asthma." British Homeopathic Journal 78, no. 03 (July 1990): 135–37. http://dx.doi.org/10.1016/s0007-0785(05)80331-x.

Full text
Abstract:
AbstractSuccessful treatment with a homœopathic drug may be considered scientific proof. Every cure verifies the hypothesis established in selecting the indicated drug for a particular patient according to the law of similars, for the drug does not act unless it matches the complete range of symptoms presented by the patient in question, covering aetiology, mental symptoms, constitution, the type of disorder involved and local symptoms.Two patients, each with a long history of allergic asthma, are presented. Sepia proved effective, with both patients practically symptom-free for two years. The drug picture of Sepia is discussed with regard to both aetiology and constitution, as are other current views concerning the causes of allergic diseases of the respiratory tract. Noteworthy aspects are suppressed infectious conditions, sycosis (lithaemic and rheumatic diathesis combined) and lack of reactivity.
APA, Harvard, Vancouver, ISO, and other styles
6

Leonardi, Salvatore, Giuseppe Marchese, Gian Luigi Marseglia, and Mario La Rosa. "Montelukast in allergic diseases beyond asthma." Allergy and Asthma Proceedings 28, no. 3 (May 1, 2007): 287–91. http://dx.doi.org/10.2500/aap.2007.28.2955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Peebles, R. Stokes. "Prostaglandins in asthma and allergic diseases." Pharmacology & Therapeutics 193 (January 2019): 1–19. http://dx.doi.org/10.1016/j.pharmthera.2018.08.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pali-Schöll, Isabella, Cassim Motala, and Erika Jensen-Jarolim. "Asthma and Allergic Diseases in Pregnancy." World Allergy Organization Journal 2, no. 3 (2009): 26–36. http://dx.doi.org/10.1186/1939-4551-2-3-26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pali-Schöll, Isabella, Cassim Motala, and Erika Jensen-Jarolim. "Asthma and Allergic Diseases in Pregnancy." World Allergy Organization Journal 2, no. 3 (March 2009): 26–36. http://dx.doi.org/10.1097/wox.0b013e31819b0a86.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

TePas, Elizabeth C., and Dale T. Umetsu. "Immunotherapy of asthma and allergic diseases." Current Opinion in Pediatrics 12, no. 6 (December 2000): 574–78. http://dx.doi.org/10.1097/00008480-200012000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Bakers asthma; allergic diseases"

1

Sandiford, Colin Paul Ebenezer. "Characterization of allergens involved in the development of an immunoassay for their measurement in air." Thesis, Imperial College London, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chongo-Faruk, Vânia. "Skin symptoms (allergic and non-allergic) predicting the development of allergic respiratory outcomes and asthma in bakers." Master's thesis, Faculty of Health Sciences, 2020. http://hdl.handle.net/11427/31487.

Full text
Abstract:
Background: Recent studies have suggested that aside from the inhalational route, skin exposure may also play an important role in the sensitization to allergens, resulting in adverse allergic respiratory outcomes including asthma in workers exposed to these agents. This appears to be reported more commonly for low molecular weight agents such as isocyanates and some cleaning agents. This study investigated whether skin symptoms, in the presence or absence of allergic sensitization, can predict the development of allergic respiratory outcomes and asthma in bakery workers. Methods: A cohort study investigated 263 bakery workers using a modified ECRHS questionnaire; immunological tests including skin prick tests for common local aeroallergens (ALK-Abello´ A/S, Horsholm, Denmark), Phadiatop and serum-specific IgE to bakery allergens (wheat, rye and fungal α-amylase); and pulmonological tests including spirometry, non-specific bronchial hyperresponsiveness, and fractional exhaled nitric oxide (FeNO), after a 4 year period. Results: Workers’ median age was 32 years (IQR: 26-38), 50% were female, 54% were ever smokers and 32% were atopic. At baseline, 26% of workers were sensitized to bakery allergens, skin symptoms were present in 22% and 11% reported work-related skin symptoms (WRSS). 3 While the incidence of general upper (19%) and lower (22%) respiratory symptoms over the follow-up period were very similar, work-related upper (29%) respiratory symptoms were higher than lower (20%) respiratory symptoms. However, the incidence of allergic sensitization to bakery allergens was only 8% and a new asthma diagnosis present in 4% over this period. In multivariate adjusted (gender, atopy and smoking status) regression models, having a history of skin symptoms was associated with an increased risk of developing work-related lower respiratory symptoms - WRLRS (RR=2.2, 95% CI: 1.03-4.83), while having clinically significant symptoms of eczema or urticaria was associated with an increased risk of reporting general upper respiratory symptoms (RR=5.5, 95% CI: 1.30-24.20) as well as WRLRS (RR= 4.8, 95% CI: 1.60-14.40). Furthermore, WRSS was associated with an increased risk of general upper respiratory symptoms (RR=5.1, 95% CI: 1.31-19.81), WRLRS (RR=4.1, 95% CI: 1.43-11.85) and elevated FeNO levels (FeNO>25ppb: RR=2.9, 95% CI: 1.19-7.28). The association between clinically significant skin symptoms or WRSS and new onset upper or lower respiratory symptoms were modified by use of dermal personal protective equipment. Infrequent or absent glove usage was associated with a higher risk (RR=5.3, 95% CI: 1.54-18.43) of having new onset WRLRS. Conclusion: Skin symptoms, more so if work-related, appear to be associated with future development of general and work-related upper and lower respiratory symptoms and inflammatory markers suggestive of asthma in bakery workers.
APA, Harvard, Vancouver, ISO, and other styles
3

Simpson, Angela. "Genetic and Environmental Factors in Asthma and Allergic Diseases." Thesis, University of Manchester, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.505521.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Al-Maskari, Fatma Nasser Saeed. "Childhood asthma : a study of the prevalence of asthma among school children aged 6-13 years in the United Arab Emirates." Thesis, University of Aberdeen, 2000. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU602007.

Full text
Abstract:
This study showed a strong association between asthma, hay fever, and eczema in the same child. The presence of pets outdoors but not indoors appeared to be associated with an increased incidence of wheezing in children. Use of the traditional Gulf incense also appeared to be a precipitating factor for asthma in this study. There were also statistically significant relationships between asthma and exposure to dust at home from air conditioner blasts, which is consistent with studies elsewhere. Moreover, in this study, passive exposure to tobacco smoking at home did not appear to have any significant relationship with asthma. There was, however, a statistically significant relationship between asthma and exposure to pollen from indoor plants, which is also consistent with studies elsewhere. Parental asthma but not parental atopy was a significant risk factor for asthma in offspring, a finding which agrees with other studies that have shown that parental atopy may enhance the likelihood of the expression of asthma, but does not, on its own, impact as a risk factor in the same way as parental asthma. There was a statistically significant difference in the prevalence of asthma and the symptoms of asthma between different areas across the United Arab Emirates, but not for eczema or hay fever. This is most likely attributable to the impact of radically different environmental conditions on the development of allergies in two genetically homogenous populations of United Arab Emirates nationals. Asthma, wheeze, dyspnoea and nocturnal cough were more prevalent in coastal humid Dubai, compared to dry inland Al-Ain. However, there was no statistically significant difference in the prevalence of eczema and hay fever between coastal and inland areas in the United Arab Emirates. An environmental survey carried out in Dubai and Al-Ain to study the effect of air pollution among asthmatic children showed that overall air quality in both Dubai and in Al-Ain is good, except during adverse weather conditions, strong winds and dust storms, in summer time, where the level of Respirable Particulates (PM10) is occasionally high in Dubai. However, a previous study of seasonal trends in hospital admissions for asthmatic children in Dubai showed that the highest numbers of admissions for asthmatic children occurred between the months of October and February. These are the coldest months of the year in the United Arab Emirates. Therefore air pollution from dust storms was not the cause of the high prevalence of asthma in Dubai. Although the prevalence of asthma and wheezing was lower in the United Arab Emirates than in some developed countries, it was still higher than other chronic diseases. This study demonstrated that symptoms suggestive of asthma are quite common and constitute a major health problem in the United Arab Emirates. High rates of consanguineous marriage, a buoyant economy, rapid industrialization, development of the agricultural sector, an increase in the domestication of animals and dairy farms, combined with an emphasis on 'greening' the environment, may have resulted in an increase of the prevalence of asthma. World-wide trends have been in this direction. Therefore, a concentrated effort should be made to implement therapeutic and non-therapeutic programmes for the management of asthma by parents, teachers and physicians.
APA, Harvard, Vancouver, ISO, and other styles
5

Farahani, Mosavar. "Regulation of histamine H←1-receptor coupling and expression in cultured human airway smooth muscle cells." Thesis, University of Nottingham, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.263099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hedman, Linnea. "Epidemiological studies of asthma and allergic diseases in teenagers methodological aspects and tobacco use /." Doctoral thesis, Umeå : Umeå university, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-31292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sporik, Richard Bernard. "The natural history of allergic diseases in children : a prospective clinical, immunological and environmental study." Thesis, University of Southampton, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.295805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wittchen, Hans-Ulrich, Stephan Mühlig, Jens Klotsche, P. Kardos, T. Ritz, and Oliver Riedel. "Omalizumab versus ‘Usual Care’: Results from a Naturalistic Longitudinal Study in Routine Care." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2013. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-117621.

Full text
Abstract:
Background: It is unclear how far the superior efficacy of omalizumab, established in randomized controlled clinical trials of patients with severe allergic asthma (SAA), translates into routine practice and when compared to matched controls. Methods: New-onset omalizumab-treated (OT) patients with SAA (n = 53) were compared to a matched control group of usual-care (UC) patients (n = 53). Treatment and procedures were naturalistic. Subsequent to a baseline assessment, patients were followed up over at least 6 months with at least two follow-up assessments. Primary clinical outcomes were the number of asthma attacks, persistence of asthma symptoms and degree of control [asthma control test (ACT), Global Initiative for Asthma]. Secondary outcome criteria were quality of life (Euro-Qol 5D) and number of medications. For each outcome we compared within-group effects from baseline to 6-month follow-up as well as between-group effects. Results: OT patients showed significant improvements in number [effect size (ES) = 0.03] and frequency (ES = 0.04) of asthma attacks as well as asthma control (ES = 0.09), whereas controls revealed no significant improvements in these measures. Further improvements in the OT group were found for ‘perceived control always’ (ACT, p = 0.006), no impairment (ACT, p = 0.02), reduction of sickness days (p = 0.002) and number of medications needed (p = 0.001). Conclusions: Substantial beneficial effects of omalizumab, similar to those observed in controlled trials and after marketing studies, were confirmed, particularly with regard to the reduction of asthma attacks, persistence of symptoms, asthma control and reduction of concomitant asthma medications. This study provides a tougher test and generalizable evidence for the effectiveness of omalizumab in routine care.
APA, Harvard, Vancouver, ISO, and other styles
9

Chu, Thi Ha. "Phenotyping of chronic respiratory diseases in the South of Vietnam." Doctoral thesis, Universite Libre de Bruxelles, 2019. https://dipot.ulb.ac.be/dspace/bitstream/2013/288355/4/coverpage.pdf.

Full text
Abstract:
Chronic respiratory diseases (CRDs) include chronic diseases involving the airways and other structures of the lung. In the current circumstance of Vietnam, people are exposed to numerous risk factors of CRD, such as heavy smoking, high frequency of pulmonary tuberculosis, chronic helminthiasis, allergic factors, migration and urbanization (the last associated with traffic-related pollution). The phenotype diagnoses should take into account the risk factors of each individual besides the clinical features, while the differential diagnoses mostly depend on the available techniques in each healthcare center. Our aim was to improve the differential diagnoses of the 3 most frequent CRDs: chronic obstructive pulmonary disease (COPD), asthma and COPD – asthma overlap syndrome (ACOS), in Vietnam. In the first part, we evaluated the prevalence of the allergen sensitization among patients with CRD, in regard to the urban and rural area in the South of Vietnam. House dust mites and cockroach droppings were the most frequent sensitizer. Compared with participants born in the urban setting, those born in the rural environment were less frequently sensitized and this protective effect disappeared in the case of migration from rural to urban areas. In the second part, we evaluated skin prick test as a method to screen dust mite sensitization in CRD in southern Vietnam. The data suggested that, in the present circumstance, skin prick test can be used to screen mite sensitization. In the third part, we evaluated the risk of mite sensitization in the native and migrant population, in regard to several environmental factors. Consistently with the hygiene hypothesis, compared to urban, exposure to high endotoxin concentration in rural was a protective factor against allergic sensitization. We reported for the first time that this effect was reversible among the migrants from rural to urban setting in association with lower endotoxin exposure. In the fourth part, we have defined asthma, COPD and ACOS based on clinical symptoms, cumulative smoking and airway expiratory flow with reversibility, on one side, and the age-related of the different phenotypes, on the other side. We hypothesized that the cumulative exposure to noxious particles should increase the age-related prevalence of COPD, while due to the immunosenescence process, the prevalence of IgE-mediated asthma should decrease with age, and ACOS prevalence being not related to age due to the combined mechanisms.  In conclusion, we showed in the South of Vietnam that:1) mites and cockroach allergens were the most frequent sensitizer in chronic respiratory diseases;2) the skin prick test to mite has been validated to screen mite sensitization;3) associated with a reduced level of endotoxin level, migration from rural to the urban setting was a risk factor of mite sensitization in chronic respiratory diseases;4) based on the clinical symptoms, spirometric values, and cumulative smoking, the diagnosis of asthma, COPD and ACOS have been made and their prevalence were 25, 42 and 33%, respectively.
Doctorat en Sciences biomédicales et pharmaceutiques (Médecine)
info:eu-repo/semantics/nonPublished
APA, Harvard, Vancouver, ISO, and other styles
10

Conde, García Eva. "Anti -IL-4, -IL-13 and -IgE vaccination for the treatment of allergic diseases." Thesis, Sorbonne université, 2020. https://accesdistant.sorbonne-universite.fr/login?url=http://theses-intra.upmc.fr/modules/resources/download/theses/2020SORUS011.pdf.

Full text
Abstract:
Les allergies représentent un problème de santé majeur avec une prévalence en nette augmentation et pour lesquelles il n’existe pas de thérapie à longue durée. L’IL-4, l’IL-13 et l'IgE jouent un rôle clé dans les réactions allergiques. Ces cibles thérapeutiques ont été validées en clinique, grâce aux anticorps monoclonaux. Néanmoins, leur utilisation reste contraignante de par leur coût excessif et la nécessité de réinjections fréquentes. L’objectif de cette thèse a été de développer des vaccins contre l’IL-4, l’IL-13 et l’IgE, appelés kinoïdes, et d’apporter la preuve de concept de l’efficacité dans des modèles d’asthme et de choc allergique. Nous avons démontré qu’une vaccination combinée contre l’IL-4 et l’IL-13 permet de réduire les taux d’IgE, l’hyperréactivité bronchique, l’éosinophilie et la production de mucus dans un modèle murin d’asthme chronique. De plus, nous avons montré qu’une vaccination avec des kinoïdes IL-4/IL-13 humains induit des anticorps neutralisants anti-IL-4 et IL-13 humaines et et réduit les niveaux d’IgE dans des souris humanisées pour l’IL-4, l’IL-13 et IL-4Ra. Nous avons également développé un vaccin conjugué contre l’IgE humaine. Nous avons montré que ce vaccin induit une forte production d’anticorps neutralisant anti-IgE humains, dans une nouvelle souche de souris humanisée pour l’IgE et le récepteur FceRI. Une vaccination des souris humanisées IgE/FceRI avec le kinoïde IgE humain réduit fortement les taux d’IgE et protège contre un choc anaphylactique induit par les IgE. L’ensemble de ces études démontre qu’une vaccination contre l’IL-4, l’IL-13 ou l’IgE pourrait représenter une solution thérapeutique contre les maladies allergiques
Allergies represent major public health problems of increasing prevalence and for which there is still no efficient long-term therapy. IL-4 and IL-13, and IgE play key roles in allergic reactions, and therefore represent good therapeutic targets. These targets have been clinically validated with approved monoclonal antibodies (mAb). However, use of mAb is limited by high cost and the need to perform repeated injections. Therefore, there is a clear need to improve current strategies in order to reach long term effects. The objective of this thesis was to develop anti-IL-4, anti-IL-13 and anti-IgE vaccines called kinoids, and provide a proof-of-concept of their safety and efficacy. We developed conjugate vaccines against IL-4 and IL-13, and demonstrated their prophylactic and therapeutic efficacy in reducing IgE levels, airway hyperresponsiveness, eosinophilia and mucus production in a house dust mite-induced mouse model of asthma without any detectable adverse effect. The human version of the IL-4/IL-13 kinoid was also efficient at neutralizing human IL-4 and IL-13, and reducing IgE levels in mice humanized for IL-4, IL-13 and their common receptor subunit IL-4Ra. In addition, we also developed a conjugate vaccine against human IgE. We showed that this anti-IgE vaccine induces long-term production of anti-human IgE neutralizing antibodies in a novel mouse strain we characterized and which is humanized for IgE and its high-affinity receptor FceRI. Anti-human IgE vaccination reduced hIgE, and fully protected against IgE-mediated anaphylaxis. Altogether, our results showed that vaccination against IL-4, IL-13 and IgE could be a valuable strategy to target allergic disorders
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Bakers asthma; allergic diseases"

1

Namazy, Jennifer A., and Michael Schatz, eds. Asthma, Allergic and Immunologic Diseases During Pregnancy. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03395-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gern, James E. Contemporary diagnosis and management of allergic diseases and asthma. 3rd ed. Newton, Pa: Handbooks in Health Care, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

W, Busse W., ed. Contemporary diagnosis and management of allergic diseases and asthma. 2nd ed. Newton, Pa: Handbooks in Health Care, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gern, James E. Contemporary diagnosis and management of allergic diseases and asthma. 5th ed. Newtown, Pa: Handbooks in Health Care Co., 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gern, James E. Contemporary diagnosis and management of allergic diseases and asthma. Newton, Pa: Handbooks in Health Care, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Busse, W. W. (William W.), ed. Contemporary diagnosis and management of allergic diseases and asthma. 6th ed. Newtown, Pa: Handbooks in Health Care Co., 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

International, Conference on Asthma (5th 1997 Ischia Italy). Asthma and allergic diseases: Physiology, immunopharmacology, and treatment : fifth international symposium. San Diego: Academic Press, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pereira, Celso. Allergic diseases - highlights in the clinic, mechanisms and treatment. Rijeka: InTech, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

B, Kay A., ed. Allergy and allergic diseases. 2nd ed. Malden, Mass: Blackwell, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Robinson, D. S., ed. Immunological Mechanisms in Asthma and Allergic Diseases. S. Karger AG, 2000. http://dx.doi.org/10.1159/isbn.978-3-318-00611-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Bakers asthma; allergic diseases"

1

Kaliner, Michael A. "Asthma in Adults." In Allergic Diseases, 123–57. Totowa, NJ: Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-007-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Li, Huamin Henry, and Michael A. Kaliner. "Asthma in Adults." In Allergic Diseases, 107–41. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-382-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Spahn, Joseph D., and Stanley J. Szefler. "Glucocorticoid Therapy in Asthma." In Allergic Diseases, 385–404. Totowa, NJ: Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-007-0_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shapiro, Gail G., C. Warren Bierman, and Frank S. Virant. "The Child with Asthma." In Allergic Diseases, 85–122. Totowa, NJ: Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-007-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yoshida, Satoshi. "Allergic Ocular Diseases." In Allergy and Asthma, 113–42. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-05147-1_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yoshida, Satoshi. "Allergic Ocular Diseases." In Allergy and Asthma, 1–30. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-58726-4_4-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bardana, Emil J. "Occupational Asthma." In Atlas of Allergic Diseases, 191–201. London: Current Medicine Group, 2002. http://dx.doi.org/10.1007/978-1-4615-6481-2_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Spector, Sheldon L. "Antileukotriene Agents in the Management of Asthma." In Allergic Diseases, 361–66. Totowa, NJ: Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-007-0_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Doll, Rayna J., Nancy I. Joseph, David McGarry, Devi Jhaveri, Theodore Sher, and Robert Hostoffer. "Epidemiology of Allergic Diseases." In Allergy and Asthma, 31–51. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-05147-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Helen, Zachary Marshall, Nicholas Rider, and David B. Corry. "Cough and Allergic Diseases." In Allergy and Asthma, 469–78. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-05147-1_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Bakers asthma; allergic diseases"

1

Baatjies, Roslynn, and Mohamed Jeebhay. "0285 Assessing the impact of a group randomised controlled intervention study in supermarket bakeries with a high baker’s allergy and asthma burden." In Eliminating Occupational Disease: Translating Research into Action, EPICOH 2017, EPICOH 2017, 28–31 August 2017, Edinburgh, UK. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/oemed-2017-104636.235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lopes Teixeira Arrais, Margarete, Ofélia Lulua, Francisca Quifica, Jorge Gama, Luis Taborda-Barata, and Miguel Brito. "Allergic sensitisation and relationship with asthma and other allergic diseases in children in the province of Bengo, Angola." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4500.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Haldar, Prasun, Smriti Debnath, Santi Gopal Maity, Ritabrata Mitra, Moumita Biswas, Soumya Bhattacharjee, Sujoy Saha, et al. "Association between asthma and allergic diseases and circadian preference (chronotype) of the adolescents." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2783.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Debnath, Smriti, Prasun Haldar, Santi Gopal Maity, Ritabrata Mitra, Moumita Biswas, Soumya Bhattacharjee, Sujoy Saha, et al. "Environmental factors in asthma and allergic diseases among the Indian adolescents: PERFORMANCE study results." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4409.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brożek, Grzegorz, Mateusz Jankowski, Agnieszka Jarosinska, Jan Zejda, Krzysztof Kocot, Justyna Gawlewicz, Joanna Lenart, Maciej Nowak, Wojciech Mrowicki, and Bartlomiej Nowak. "Prevalence of asthma, respiratory symptoms and allergic diseases in children aged 6-9 in Katowice (Poland)." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa5071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pesce, Giancarlo, Nour Baiz, Guy Huel, and Isabella Annesi Maesano. "Foetal exposure to heavy metals and risk of asthma and allergic diseases in early childhood: a population-based birth-cohort study." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.3847.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Silva, Lui´s F., Senhorinha Teixeira, Jose´ Carlos Teixeira, Rita Rebelo, Ricardo Oliveira, and Henedina Antunes. "Study and Development of Spacers for Pressurized Inhaler Devices: A Project Review." In ASME 2009 International Mechanical Engineering Congress and Exposition. ASMEDC, 2009. http://dx.doi.org/10.1115/imece2009-13171.

Full text
Abstract:
In recent years, allergic diseases, particularly asthma, have been acquiring an increasing importance in the developed countries, due to the rising of its prevalence and morbidity and the economic burden associated, becoming a serious public health problem. Recent therapeutic approaches in asthma patients may help to prevent most of the crisis and remain free of symptoms. Several inhalation devices are available for drug delivery to the lungs, including metered-dose inhalers (MDIs), dry powder inhalers (PDIs) and nebulizers. Although this variety of devices used for drug delivery to the bronchial tree have shown encouraging results, a great amount of the drug does not reach the goal and remains in the mouth (less than 20% of the drug can reach the lungs) and higher airways. This causes not only a loss of drug but also increases costs and produces undesirable side effects. For better efficiency of the process, spacers, such as the Volumatic® used in the study herein reported, are used. This paper will describe and summarize part of the developments being carried out so far at the University of Minho in this domain, as well as the latest developments in order to understand the characteristics of the used spacer and the parameters affecting its performance. By using computational fluid Dynamics (CFD) techniques, the behavior of the drug flow inside the spacer, combined with a pressurized metered-dose inhaler (pMDI), the discrete phase model (DPM) flow inside the Volumatic® is also reported. The results obtained are also analyzed and discussed, using two different 3D grid types (Cooper and T-Grid). The insight provided by the detailed data of the flow patterns inside the Volumatic® provides possible options for new geometry possibilities for the spacer devices.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Bakers asthma; allergic diseases' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography